We have been using clia-waived drug tests as a way to effectively screen patients and be reasonably reimbursed. Recently there has been a change in coding regarding billing for clia-waived tests with a change in G0431 and G0434. Given the costs of clia-waived test and the significant decrease in reimbursement how are others handling this? It seems that clia-waived testing in the office is no longer reasonable.